Nonavalent HPV study vaccine: Clinical Trials

1 trial of Nonavalent HPV study vaccine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow Nonavalent HPV study vaccine: new trials by email Literature Review of Nonavalent HPV study vaccine trials Research Report on Nonavalent HPV study vaccine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine
Nonavalent HPV study vaccine, GARDASIL® 9 - Human Papillomavirus Infection
Phase 3UnknownBeijing Health Guard Biotechnology, Inc12602023-11-212024-01-23

Conditions studied

Papillomavirus Infections (1)

Sponsors

Beijing Health Guard Biotechnology, Inc (1)

Countries

Indonesia (1)

Top investigators

Yu Hongyang (1)